
Sign up to save your podcasts
Or


In this episode, Nick Chmielewski speaks with David Wildebrandt, a partner and managing director at BRG. They discuss key findings from BRG's recent 2025 US Healthcare & Life Sciences Transactions Outlook report, including transactional evolution and industry disruptors.
By BRG5
88 ratings
In this episode, Nick Chmielewski speaks with David Wildebrandt, a partner and managing director at BRG. They discuss key findings from BRG's recent 2025 US Healthcare & Life Sciences Transactions Outlook report, including transactional evolution and industry disruptors.

91,051 Listeners

1,457 Listeners

1,032 Listeners

112,327 Listeners

56,404 Listeners

5,444 Listeners

6,370 Listeners

805 Listeners

31 Listeners

2,096 Listeners

665 Listeners

24 Listeners

7,858 Listeners

20,347 Listeners